CNO
Cno Financial Group, Inc. Financials Accident & Health Insurance Russell 3000
$57.67Close
$5.4BMarket cap
$39.11 – $57.6752-week range
Late-januaryNext report · estimated
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 81 · stronger than 81% of stocks over 12 months
- RS line at a 1-year high outperforming the S&P 500 more than at any point this year
- Near its high at its 52-week high
- Earnings growing EPS +45% year on year
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
0%
1wk
up 7.5%
price change
1mo
up 9.0%
price change
12-month return
up 46%
market up 11% ·
its own up 36%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
23.8×
price / earnings
PEG
—
P/E / EPS growth
P/B
2.1×
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 1%
year on year
EPS growth
up 45%
latest quarter · -43 pts
Sales growth
up 12%
latest quarter · +9 pts
ROE
up 9%
return on equity
Free cash margin
—
D/E
0.51
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- Long-term debt down 27% ($1.9B → $1.4B)
Trade setup
ATR%
2.0%
$1.13 a day · 2×ATR $55.40
RS
81 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
1.0×
vs 50-day average
Up/down volume
1.37
50 sessions
Implied move
—
no scheduled report
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- No material dilution
- Margins and revenue not shrinking
Last reported
Oct 29, 2026
Results reaction
Oct 29, 2026+8% vs market2 sessions after results
Financials
- Net 5%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $3.8B | $4.1B | $3.6B | $4.1B | $4.4B | $4.5B |
| Operating income | $463.8M | $514.7M | $466.7M | $459.5M | $550.8M | $553.2M |
| Net income | $301.8M | $570.3M | $630.6M | $276.5M | $420.8M | $229.3M |
| Net margin | 8% | 14% | 18% | 7% | 9% | 5% |
| Earnings per share | $2.11 | $4.35 | $5.36 | $2.40 | $3.89 | $2.30 |
| Cash | $991.9M | $731.7M | $644.9M | $889.0M | $2.0B | $983.5M |
| Long-term debt | $1.1B | $1.1B | $1.1B | $1.1B | $1.9B | $1.4B |
| Shareholders' equity | $5.5B | $3.7B | $1.8B | $2.2B | $2.5B | $2.6B |
| Shares outstanding | 135.28m | 120.38m | 114.34m | 109.36m | 101.62m | 94.48m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 26, 2025 | Annual ↗ | Dec 31, 2024 | 57d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 6, 2024 | Quarterly ↗ | Mar 31, 2024 | 36d |
| Feb 23, 2024 | Annual ↗ | Dec 31, 2023 | 54d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Results ↗ |
| Sep 1, 2026 | Regulation FD ↗ |
| Jul 30, 2026 | Results ↗ |
| May 13, 2026 | Shareholder vote ↗ |
| Apr 30, 2026 | Results ↗ |
| Feb 11, 2026 | Director or officer change · Regulation FD ↗ |
| Feb 5, 2026 | Results ↗ |
| Jan 15, 2026 | Director or officer change ↗ |
| Nov 3, 2025 | Results ↗ |
| Sep 10, 2025 | Regulation FD ↗ |
| Jul 28, 2025 | Results ↗ |
| Jun 10, 2025 | Regulation FD ↗ |